Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 17.05
-11.4 %
$ 492 M
Market Cap
26.81
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Castle Biosciences, Inc.
| Revenue | 332 M |
| Cost Of Revenue | 60.2 M |
| Gross Profit | 272 M |
| Operating Expenses | 263 M |
| Operating Income | 8.67 M |
| Other Expenses | -9.58 M |
| Net Income | 18.2 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 332.1 | 219.8 | 137.0 | 94.1 | 62.6 | 51.9 | 22.8 | 13.8 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 60.2 | 45.0 | 32.0 | 15.8 | 9.7 | 7.3 | 5.3 | 4.9 |
| Gross Profit | 271.9 | 174.8 | 105.0 | 78.3 | 53.0 | 44.6 | 17.5 | 8.8 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 263.2 | 242.8 | 196.2 | 118.3 | 59.5 | 37.2 | 21.3 | 19.7 |
| Selling, General and Administrative Expenses | 200.0 | 180.2 | 143.0 | 86.7 | 48.1 | 29.8 | 16.5 | 15.3 |
| Research and Development Expenses | 52.0 | 53.6 | 44.9 | 29.6 | 13.3 | 7.4 | 4.9 | 4.5 |
| Operating Income | 8.7 | (68.0) | (91.1) | (40.1) | (6.5) | 4.7 | (3.8) | (10.9) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0.6 | 11 K | 17 K | 1 K | 2.6 | 4.6 | 2.3 | 1.6 |
| Total Other Income | 12.9 | 10.6 | 4.0 | 67 K | (3.7) | (2.0) | (2.5) | (1.5) |
| Pre-Tax Income | 21.6 | (57.4) | (68.9) | (40.0) | (10.2) | 5.3 | (6.4) | (12.4) |
| NET INCOME | ||||||||
| Tax Provision | 3.3 | 0.1 | (1.8) | (8.7) | 84 K | 72 K | 8.61 K | 9.73 K |
| Net Income | 18.2 | (57.5) | (67.1) | (31.3) | (10.3) | 5.3 | (6.4) | (12.4) |
| EPS | 0.66 | 2.14 | 2.58 | 1.24 | 0.54 | 0.35 | 0.6 | 1.26 |